If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.95m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Trading Update

18 May 2011 07:00

RNS Number : 7877G
Merchant Securities Group PLC
18 May 2011
 



 

 

AIM: MERC

 

 

 

MERCHANT SERCURITIES GROUP PLC

("Merchant Securities" or "the Group")

 

Trading Update

 

Merchant Securities, the financial services group, is pleased to provide the following update on trading for the year ended 31 March 2011.

 

Revenue for the 12 months to 31 March 2011, subject to audit, is expected to show year on year growth of 10% to £8.4 million (2010: £7.61 million). Profit before taxation, amortisation and non-recurring items is expected to show a rise of approximately 36% to £1.1 million (2010: £0.83 million). Non-recurring items relate primarily to the Group's move to a single larger London office. The Group's balance sheet remains strong, with no debt, and cash balances at 31 March 2011 stood at £2.6 million (2010: net cash of £3.1 million). This is stated after costs associated with the move to new offices and the acquisition of GT Independent Financial Advisers Limited ("GT") mentioned below. 

 

The Board is satisfied with the Group's progress in the year. A key highlight was the acquisition of GT, an independent wealth management firm, in February 2011. Its addition has more than doubled the Group's assets under advisory and discretionary management, which stood at approximately £486 million as at 31 March 2011, and is in line with the Board's strategy to expand Merchant Securities' wealth management division. Merchant Securities' corporate finance and advisory activities have performed well in a difficult marketplace. 

 

Results for the year are expected to be issued at the end of July. 

 

 

For further information, please contact:

 

  

Merchant Securities Group plc 

Patrick Claridge, Chief Executive

 T: 020 7375 9022
   
Arden Partners plc

Richard Day

 

 T: 020 7614 5917
Biddicks

Katie Tzouliadis/Sophie Lane

 T: 020 3178 6378

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFMWFFSELI
Date   Source Headline
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.